An Open-label, Randomized, Fasting, Single, Group 2, Stage 2, Cross-over Study to Evaluate the Safety and Pharmacokinetics of AG2304 Compared to Coadministration of AG23041 and AG23042 in Healthy Adult Volunteers
Latest Information Update: 16 Apr 2025
At a glance
- Drugs AG 2304 (Primary)
- Indications Hypercholesterolaemia
- Focus Pharmacokinetics
- Sponsors Ahn-Gook Pharmaceutical
Most Recent Events
- 16 Apr 2025 New trial record